Literature DB >> 14693487

Cimetidine treatment for viral warts enhances IL-2 and IFN-gamma expression but not IL-18 expression in lesional skin.

Tsuyoshi Mitsuishi1, Kazumi Iida, Seiji Kawana.   

Abstract

Cimetidine has been shown to improve various types of human neoplasms and more recently it has been shown to be effective in treating recalcitrant or multiple viral warts in some reports. However, it is not well understood why cimetidine is effective on those kinds of viral warts. We investigated 55 patients with multiple viral warts treated only with oral cimetidine for up to 4 months to examine the efficacy of treatment. The patients were divided into two groups: group A received oral cimetidine (<20 mg/kg/day) and group B received the drug (30 to 40 mg/kg/day). In addition, using real time PCR, we measured mRNA levels of the cytokines interleukin-2 (IL-2), IL-18, and interferon (IFN)-gamma taken from selected punch biopsy specimens before and during treatment. As a result, 34.5% (19/55) of the patients had a dramatic clinical improvement or complete remission (CR) of their viral warts and 23.6% (13/55) of the patients had partial responses (PR) within 4 months of cimetidine therapy. IL-2 and IFN-gamma mRNA levels were significantly increased and IL-18 mRNA levels were decreased in tissues of effectively treated viral warts. Our results show that the higher dose of oral cimetidine was more effective in treating multiple viral warts, that cimetidine activates Th1 cells to produce IL-2 and IFN-c and that their expression correlates with wart remission. These results suggest that cimetidine is an effective treatment for viral warts. In addition, based on the decrease in IL-18 mRNA elicited by the drug, IL-18 might be expressed by keratinocytes infected with HPV.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14693487

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  6 in total

Review 1.  An armamentarium of wart treatments.

Authors:  Michelle M Lipke
Journal:  Clin Med Res       Date:  2006-12

Review 2.  Immunomodulators in warts: Unexplored or ineffective?

Authors:  Surabhi Sinha; Vineet Relhan; Vijay K Garg
Journal:  Indian J Dermatol       Date:  2015 Mar-Apr       Impact factor: 1.494

Review 3.  Evolving role of immunotherapy in the treatment of refractory warts.

Authors:  Devinder M Thappa; Minu J Chiramel
Journal:  Indian Dermatol Online J       Date:  2016 Sep-Oct

Review 4.  Interferons as therapeutic agents for infectious diseases.

Authors:  Scott J Bergman; McKenzie C Ferguson; Cathy Santanello
Journal:  Infect Dis Clin North Am       Date:  2011-12       Impact factor: 5.982

5.  Changes in Cytokine Profile with Immunotherapy in Viral Warts using Purified Protein Derivative, Mumps Measles Rubella Vaccine, and Mycobacterium w Vaccine.

Authors:  Amrita Sil; Sayantan Dasgupta; Somodyuti Chandra; Adrija Datta; Arini Banerjee; Nilay Kanti Das
Journal:  Indian J Dermatol       Date:  2021 Jan-Feb       Impact factor: 1.494

6.  Cimetidine: A Safe Treatment Option for Cutaneous Warts in Pediatric Heart Transplant Recipients.

Authors:  Bibhuti B Das; Kristin Anton; Nelia Soares; Susan Riojas; Jodi Mcdermott; Leah Knox; Susan Daneman; Bao N Puente
Journal:  Med Sci (Basel)       Date:  2018-04-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.